Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study
- PMID: 7964903
- DOI: 10.1097/00005072-199411000-00010
Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study
Abstract
Thirty-five randomly selected plaques from five patients with longstanding multiple sclerosis were examined immunohistochemically for evidence of extravascular serum proteins. One lesion showed histological evidence of active demyelination and 34 were inactive. In the one active lesion and in 26 of the 34 inactive lesions, serum proteins were detected outside blood vessels in a distribution consistent with leakage during life. The findings suggest that the blood-brain barrier (BBB) is permanently damaged in many old plaques, although to a degree not often detectable by current gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)-enhanced magnetic resonance imaging (MRI). The findings also suggest that in patients with multiple sclerosis, a breached BBB is not by itself sufficient to induce active demyelination. Continuous exposure of demyelinated axons and glia to cytokines, antibody or other factors present in the circulation might be important, however, in preventing oligodendrocyte regeneration and new myelin formation in longstanding lesions.
Similar articles
-
Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination.J Pathol. 2003 Oct;201(2):319-27. doi: 10.1002/path.1434. J Pathol. 2003. PMID: 14517850
-
Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.Brain. 2015 Sep;138(Pt 9):2571-83. doi: 10.1093/brain/awv203. Epub 2015 Jul 17. Brain. 2015. PMID: 26187333 Free PMC article.
-
Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.Neurobiol Dis. 2005 Dec;20(3):953-60. doi: 10.1016/j.nbd.2005.06.012. Epub 2005 Jul 21. Neurobiol Dis. 2005. PMID: 16039866
-
The role of magnetic resonance techniques in understanding and managing multiple sclerosis.Brain. 1998 Jan;121 ( Pt 1):3-24. doi: 10.1093/brain/121.1.3. Brain. 1998. PMID: 9549485 Review.
-
The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis.Biochem Soc Trans. 2009 Feb;37(Pt 1):329-31. doi: 10.1042/BST0370329. Biochem Soc Trans. 2009. PMID: 19143657 Review.
Cited by
-
Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6698-703. doi: 10.1073/pnas.0303859101. Epub 2004 Apr 19. Proc Natl Acad Sci U S A. 2004. PMID: 15096619 Free PMC article.
-
Coagulation Pathways in Neurological Diseases: Multiple Sclerosis.Front Neurol. 2019 Apr 24;10:409. doi: 10.3389/fneur.2019.00409. eCollection 2019. Front Neurol. 2019. PMID: 31068896 Free PMC article. Review.
-
Progressive multiple sclerosis: pathology and pathogenesis.Nat Rev Neurol. 2012 Nov 5;8(11):647-56. doi: 10.1038/nrneurol.2012.168. Epub 2012 Sep 25. Nat Rev Neurol. 2012. PMID: 23007702 Review.
-
The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis.Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10100-5. doi: 10.1073/pnas.95.17.10100. Proc Natl Acad Sci U S A. 1998. PMID: 9707607 Free PMC article.
-
Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics.Nat Rev Neurosci. 2018 May;19(5):283-301. doi: 10.1038/nrn.2018.13. Epub 2018 Apr 5. Nat Rev Neurosci. 2018. PMID: 29618808 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical